Allogene Therapeutics Inc - ALLO - stock price prediction, stock price target, analyst ratings from 14 analysts

Allogene Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -50.0%, and profit growth estimate of 13.4% for FY25, based on top 14 analyst calls.